U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07803393) titled 'Mirogabalin Plus EBMP for IC/BPS' on Aug. 31.
Brief Summary: The goal of this clinical trial is to learn whether adding mirogabalin to educational-behavioral modification program (EBMP) improves symptoms and safety outcomes for adults living with interstitial cystitis/bladder pain syndrome (IC/BPS).
The main questions this study aims to answer are:
1. Does combined mirogabalin and EBMP treatment produce better overall symptom improvement after 12 weeks compared with EBMP alone?
2. Is combination treatment safe and well-tolerated in adults with IC/BPS?
Researchers will compare two treatment groups to test these questions. Eligibl...